PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

133 hedge funds and large institutions have $609M invested in Paratek Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
+14
Holders Change %
+11.76%
% of All Funds
3.32%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
34
Increased
48
Reduced
33
Closed
20
Calls
$8.47M
Puts
$5.15M
Net Calls
+$3.32M
Net Calls Change
-$919K

Top Buyers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
$23M
2
ECP
Empyrean Capital Partners
California
$16.8M
3
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$8.6M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
$16.6M
5
Millennium Management
Millennium Management
New York
$8.39M

Top Sellers

1
TCM
Tekla Capital Management
Massachusetts
$0
2
IVM
InterWest Venture Management
California
$0
3
AC
Aisling Capital
New York
$0
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
$0
5
A
Abingworth
United Kingdom
$26.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
NC
26
Nexthera Capital
New York
$6.08M +$4.83M +192,300 +385%
NI
27
Numeric Investors
Massachusetts
$5.85M -$865K -34,480 -13%
HCM
28
Highbridge Capital Management
New York
$5.29M +$5.29M +210,550 New
IBT
29
International Biotechnology Trust
United Kingdom
$5.07M +$3.61M +144,000 +248%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$4.91M +$155K +6,184 +3%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$4.35M +$15.1K +603 +0.3%
CS
32
Candriam SCA
Luxembourg
$4.09M -$1.61M -64,000 -28%
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
$4.05M -$981K -38,944 -19%
Invesco
34
Invesco
Georgia
$3.83M -$4.81M -191,645 -56%
Morgan Stanley
35
Morgan Stanley
New York
$3.78M +$246K +9,787 +7%
OP
36
Omni Partners
United Kingdom
$3.71M +$3.71M +147,700 New
Boston Partners
37
Boston Partners
Massachusetts
$3.36M – – –
Goldman Sachs
38
Goldman Sachs
New York
$3.15M -$159K -6,352 -5%
GP
39
GLG Partners
United Kingdom
$3.12M +$3.12M +124,418 New
FPC
40
Falcon Point Capital
California
$3.12M +$2.61M +121,796 +508%
SSA
41
Schonfeld Strategic Advisors
New York
$3.11M -$530K -21,112 -15%
Russell Investments Group
42
Russell Investments Group
United Kingdom
$2.98M +$1.37M +54,746 +86%
CCI
43
Columbus Circle Investors
$2.66M +$2.16M +85,990 +431%
RAM
44
Roumell Asset Management
Maryland
$2.55M -$3.92M -156,349 -61%
WIC
45
Water Island Capital
New York
$2.42M +$2.42M +96,500 New
Citadel Advisors
46
Citadel Advisors
Florida
$2.35M +$972K +38,716 +70%
Charles Schwab
47
Charles Schwab
California
$2.06M +$1.14M +45,556 +124%
RIM
48
Rainier Investment Management
Washington
$1.98M -$172K -6,870 -8%
EI
49
EAM Investors
California
$1.96M -$1.66M -66,137 -46%
SCM
50
Suffolk Capital Management
New York
$1.74M +$388K +15,439 +29%
1
2
3 4 5